CLARITY Imaging Study

  • Research type

    Research Study

  • Full title

    CLARITY Imaging Study: The Effect Of Cross-linked Sodium Hyaluronate On The Quality Of Optical Coherence Tomography Imaging

  • IRAS ID

    256498

  • Contact name

    Timothy Yap

  • Contact email

    timothyedward.yap@nhs.net

  • Sponsor organisation

    Imerial College London

  • Clinicaltrials.gov Identifier

    NCT03758859

  • Duration of Study in the UK

    0 years, 3 months, 29 days

  • Research summary

    Optical coherence tomography is an imaging technique wisely used in the field of ophthalmology to image the retinal layers at the back of the eye. This is crucially important for detecting evidence of conditions such as glaucoma and macular degeneration.

    As the imaging technique uses light energy, it is crucial the path of light in and out of the eye is optically transparent in order to provide the highest resolution possible. However, often in cases of dry eyes or ocular surface disease, images can be of substandard quality. This may lead clinicians to drawing incorrect conclusions about the presence or absence of disease progression, and therefore substandard care for patients.

    The study we are proposing will simply compare cross-linked sodium hyaluronate lubricant eye drops already licensed for use, with blinking alone or nothing. The subject will blink 5 times and the eyedrops will be instilled into one randomly selected eye in order to determine whether this intervention improves the quality of images compared to blinking alone. We will use a masked examiner, and objective signal strength scores to determine whether images taken before or after the addition of cross-linked lubricants are of higher quality. Secondary outcomes will also count the rate of errors made by automated segmentation software.

  • REC name

    London - City & East Research Ethics Committee

  • REC reference

    19/LO/0067

  • Date of REC Opinion

    15 Jan 2019

  • REC opinion

    Favourable Opinion